Patient-Customized Oligonucleotide Therapy for a Rare Genetic DiseaseJin‐Kuk Kim, Timothy W. Yu, Chunguang Hu et al.|New England Journal of Medicine|2019Cited by 808
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyJ. E. Wraith, J Zeman, Maurizio Scarpa et al.|European Journal of Pediatrics|2007Cited by 522
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseMaurizio Scarpa, J. E. Wraith, Wolfgang Kamin et al.|Orphanet Journal of Rare Diseases|2011Cited by 231
Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yieldCynthia S. Gubbels, Timothy W. Yu, Jill A. Madden et al.|Genetics in Medicine|2019Cited by 121
The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensusJoseph Muenzer, Paul Harmatz, Olaf A. Bodamer et al.|European Journal of Pediatrics|2011Cited by 112